June 20, 2018June 20, 2018

MDxHealth Announces Global Rights to Market Philips’ Prostate Cancer Prognostic Test

News

MDxHealth recently signed an agreement that gives it the worldwide licensing rights to manufacture and market its prostate cancer prognostic test that uses Philips‘ recently validated biomarker PDE4D7. MDxHealth will start ... Read more

July 11, 2017

Half of Urologists Unaware of New, More Sensitive Prostate Cancer Tests, Survey Shows

News

Half of urologists are unaware of newer, more sensitive biomarker tests for detecting prostate cancer, according to a survey of 300 of the specialists worldwide. The new tests reduce the ... Read more